Clinical trial for Prostate Cancer
Official title Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
ClinicalTrials.gov ID: NCT05918263
What this study is testing
- What it's testing
- The purpose of this study is to find out whether a 12-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among men with prostate cancer at high-risk of progression undergoing active surveillance.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Age ≥18 years.
- Histologically diagnosed with localized prostate cancer.
- Initiating or undergoing active surveillance.
- Having a higher risk of progression, defined as meeting one or more of the following: (1) favorable- intermediate risk prostate tumor at diagnosis...
- No plans for invasive treatment for their prostate cancer in the 12 weeks following the time of enrollment.
You likely can't join if
- Received any invasive curative-intent treatment for prostate cancer, including surgery, chemotherapy, radiation therapy, and hormonal therapy.
- Patients with metastasis and/or other active malignancies (except basal cell carcinoma) and/or receiving treatment for those malignancies.
- Participating in any (\>0 min/week) high-intensity exercise at the time of recruitment.
- Having chronic medical conditions that are clinically unstable or uncontrolled with medications, deemed high-risk for exercise.
- Having a high risk for noncompliance with study procedures. This will be determined by the study team based on the history of missed oncology...
- Patients who are non-English speaking and unable to complete the participant surveys.
See the full eligibility criteria
- Age ≥18 years.
- Histologically diagnosed with localized prostate cancer.
- Initiating or undergoing active surveillance.
- Having a higher risk of progression, defined as meeting one or more of the following: (1) favorable- intermediate risk prostate tumor at diagnosis, (2) obesity (body mass index ≥ 30), and/or (3) self- identified as...
- No plans for invasive treatment for their prostate cancer in the 12 weeks following the time of enrollment.
- Ability to understand and willingness to provide informed consent.
- Received any invasive curative-intent treatment for prostate cancer, including surgery, chemotherapy, radiation therapy, and hormonal therapy.
- Patients with metastasis and/or other active malignancies (except basal cell carcinoma) and/or receiving treatment for those malignancies.
- Participating in any (\>0 min/week) high-intensity exercise at the time of recruitment.
- Having chronic medical conditions that are clinically unstable or uncontrolled with medications, deemed high-risk for exercise.
- Having a high risk for noncompliance with study procedures. This will be determined by the study team based on the history of missed oncology appointments (i.e., ≥3 no-shows in 6 months) and poor responsiveness during...
- Patients who are non-English speaking and unable to complete the participant surveys.
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.